Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice
about
Bidirectional action of the Igf2r imprint control element on upstream and downstream imprinted genesThe Air noncoding RNA: an imprinted cis-silencing transcriptDecynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depressionInteraction of organic cation transporter 3 (SLC22A3) and amphetamineOATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamiliesNuclear compartmentalization of α1-adrenergic receptor signaling in adult cardiac myocytesOrganic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levelsActivation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cellsActive efflux across the blood-brain barrier: role of the solute carrier family.Glucagon effects on 3H-histamine uptake by the isolated guinea-pig heart during anaphylaxis.Taste of a pill: organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glands.Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metforminDrug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models.Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse.Extra-embryonic-specific imprinted expression is restricted to defined lineages in the post-implantation embryo.Regulation of supply and demand for maternal nutrients in mammals by imprinted genes.Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathyDrug transporters, the blood-testis barrier, and spermatogenesisThe role of imprinted genes in fetal growth abnormalities.Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metforminMolecular and cellular physiology of renal organic cation and anion transport.Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cationsTargeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells.2, 2'- and 4, 4'-Cyanines are transporter-independent in vitro dopaminergic toxins with the specificity and mechanism of toxicity similar to MPP⁺.Transporter-mediated uptake into cellular compartments.Muscarinic receptors and ligands in cancer.Excretion of biliary compounds during intrauterine life.The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.Organic anion transporter 3 inhibitors as potential novel antihypertensives.Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancy.Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importanceInvolvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice.Genomic imprinting in development, growth, behavior and stem cellsPharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.Renal transport of organic anions and cations.Multiple drug transporters mediate the placental transport of sulpiride.Molecular mechanism of histamine clearance by primary human astrocytes.Differential expression of organic cation transporter OCT-3 in oral premalignant and malignant lesions: potential implications in the antineoplastic effects of metformin.Synchronized activity of organic cation transporter 3 (Oct3/Slc22a3) and multidrug and toxin extrusion 1 (Mate1/Slc47a1) transporter in transplacental passage of MPP+ in rat.
P2860
Q24600595-EFB81BA9-B91D-4690-A50F-B9944B689F90Q24610062-F1FE0503-4D4E-4150-9B6C-F456673B0360Q24611123-9154128C-E9C3-4847-A13A-349209C70C17Q24620591-2D6C5D29-AB7B-442F-88EA-FCD1E2BEA90AQ27001267-FE3871B8-66B4-4BF9-876B-DD73BBCF3E01Q27015977-5ADA1E18-F9A6-4638-9FB1-35AC29689B9FQ28510476-8E2C1834-DD31-459F-B0DA-D629EE8B8F72Q28583028-C4DBAED6-C00A-43F5-94CE-7A3B82A92A5DQ33569358-23FF1A48-3DA0-4DA5-8672-7E5BAD7072BAQ33667252-AF09C29C-9682-4B00-8534-FE26723913F2Q34245062-972B4CBA-F4B3-45E1-B48A-7E14CD49D3A0Q34292557-0348B6C3-27A0-43B1-96D9-67B1EFAA14B0Q34513706-EAA130B0-0BA5-4D39-A877-FE496BCF859BQ34632265-200B75B3-158A-4F37-A0C8-95D9651FA235Q34851403-51BAE003-45C8-4312-8F81-1F45B69AD277Q35058363-604F49EE-E967-4EAD-98D1-674EE05C4C0AQ35071386-189411AE-CD0D-4937-BEBC-5C07FEA97B1DQ35240133-9F350EFB-1C77-4CF4-9866-E702434D962CQ35295496-15ED4365-2792-42A0-99F8-47B4BE81272DQ35745939-12D6866B-54D8-49C2-8B61-B91828694E51Q35842999-D75C36EC-7003-47B4-AD8F-07DF70770FE4Q36139458-389A2E69-035F-4CAD-9D21-9D292C9FEAC3Q36296351-1D33695C-D737-4D90-BDBC-43F93E4ED3AFQ36692394-5C6C5130-5017-45FD-8E45-E4EC7879FE07Q36985076-2862EC3F-B2BA-49E2-B892-FEADBBD798BBQ37100030-83B1598E-A13D-4531-825A-88F7BA67BF69Q37122394-EF7AA1B1-5A9E-4764-B148-B0CBD4F99285Q37194765-CB856BB4-C5FF-4A4D-8B2D-DF7E8A0922FBQ37313541-D448CD21-4385-4C66-B0AD-DDC816927C1CQ37325586-643E2419-2E42-4590-AD86-101F30F7DB48Q37432103-0C0EC59E-1EEF-4C59-8B08-48A771197F82Q37656702-1DACF71E-681C-4ABD-9DA7-896785827CD7Q37715275-DF9EEEF8-0F8A-40CD-B2EA-6A64518887CCQ38044958-956953A0-60A6-4C7C-B5C2-C81B3346563BQ38084145-13994470-663F-4673-BBDF-0430D1C7541EQ38111725-49833E9F-1AE6-4DD6-8BF6-0B3C05B43DD3Q38700777-F8F277CE-EEA5-4552-91D0-F126FBACD2DEQ39179282-6F1EE8C7-96C4-4FFE-AEAD-A13394E2F718Q39302801-9C85ED26-9BBD-4BF6-88BB-F9E83AB08647Q39356896-8EAA0E66-9803-4C98-A3EE-93632CF422ED
P2860
Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice
description
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Juli 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/07/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/07/01)
@nl
наукова стаття, опублікована в липні 2001
@uk
مقالة علمية (نشرت في يوليو 2001)
@ar
name
Impaired activity of the extra ...... n Orct3/Slc22a3-deficient mice
@ast
Impaired activity of the extra ...... n Orct3/Slc22a3-deficient mice
@en
Impaired activity of the extra ...... n Orct3/Slc22a3-deficient mice
@nl
type
label
Impaired activity of the extra ...... n Orct3/Slc22a3-deficient mice
@ast
Impaired activity of the extra ...... n Orct3/Slc22a3-deficient mice
@en
Impaired activity of the extra ...... n Orct3/Slc22a3-deficient mice
@nl
prefLabel
Impaired activity of the extra ...... n Orct3/Slc22a3-deficient mice
@ast
Impaired activity of the extra ...... n Orct3/Slc22a3-deficient mice
@en
Impaired activity of the extra ...... n Orct3/Slc22a3-deficient mice
@nl
P2093
P2860
P1476
Impaired activity of the extra ...... n Orct3/Slc22a3-deficient mice
@en
P2093
C. Popp-Snijders
D. P. Barlow
M. Buitelaar
S. Verhaagh
P2860
P304
P356
10.1128/MCB.21.13.4188-4196.2001
P407
P577
2001-07-01T00:00:00Z